Living Neurons Have Entered the Server Rack
Wetware has entered a live computing environment—but useful superiority over conventional hardware remains unproven.
Read this GVC →Grains of Vital Cognizance by Georgi V. Chaltikyan
GVCs
One consequential development. One evidence-led thesis. One question that invites a better conversation.
Latest entries
Can AI Become a Virtual Laboratory for Biology?
The promise is not replacing experiments, but deciding which experiments deserve to be done.
Read this GVC →
Can We Test Longevity Interventions Without Waiting Decades?
Responsive epigenetic clocks could accelerate longevity trials—but a younger clock is not proof of rejuvenation.
Read this GVC →
Consumer AI Is Becoming Healthcare’s Front Door
When AI shapes routing, records and transactions, it becomes healthcare infrastructure.
Read this GVC →
A Robot Can Draw Blood. What Comes Next?
The first standalone robotic blood-draw device brings supervised procedural autonomy into routine outpatient care.
Read this GVC →
Has Biomedical Publishing Crossed the AI Point of No Return?
The important question may soon be not whether AI was used in biomedical publishing, but how.
Read this GVC →
Personalized mRNA Cancer Vaccines Reach a Phase 3 Milestone
The first positive late-stage trial for a personalized mRNA cancer vaccine may mark an important precision-oncology milestone.
Read this GVC →
Predict Less. Adapt More.
Healthcare needs adaptive planning, interoperable data and governance that can evolve alongside AI capability.
Read this GVC →
Three Signals in 48 Hours: Is Medicine Entering the Age of the AI Clinical Actor?
Three developments are shifting the debate from AI as a tool toward AI as a potentially regulated clinical actor.
Read this GVC →
AI Is Learning to See the Patient. What Remains Uniquely Human?
In a simulated video OSCE, AMIE outscored primary-care physicians on clinical rubrics and perception—but it is not ready for clinical deployment.
Read this GVC →
Social Experience May Enter the Body Through the Biological Clock
Positive social experiences and childhood adversity were associated with mortality and epigenetic ageing—but the observational evidence does not establish causality.
Read this GVC →
AI Cannot Be an Author. But Can the Human Claim Its Discovery?
JAMA keeps authorship accountability human; AI-generated mathematical results challenge whether human-only credit can still describe who made the discovery.
Read this GVC →
Why a Catastrophe Caused by Artificial Intelligence May Be Inevitable
Dual-use capability races can reduce danger but cannot eliminate residual risk; resilience must prepare for consequential failure.
Read this GVC →
The Genome Remembers Reproductive Timing
Parental age and individual reproductive procedures were associated with distinct de novo mutation patterns, but population-level genomic associations must not become individual blame.
Read this GVC →
The Benchmark Ends Where Clinical AI Deployment Begins
ChatEHR’s deployment shows why clinical AI must be monitored across real workflows, unanticipated uses, human responses, and patient impact—not only pre-deployment benchmarks.
Read this GVC →
AI Found a Way into an “Undruggable” Cancer Target—but Biology Had the Final Say
AI narrowed nearly 40,000 compounds to GIPCi, but biochemical, cellular, and animal validation—not prediction alone—made it a credible preclinical candidate.
Read this GVC →
Health Apps Work. The Evidence Still Wobbles.
App-based interventions improve multiple NCD outcomes, but methodological weakness means a positive signal is not the same as trustworthy evidence.
Read this GVC →
Health AI Needs Its Own “Safe Enough” Framework
Health AI needs lifecycle safety evaluation against measurable real-world care, not a meaningless benchmark of perfection.
Read this GVC →
Can Better DNA Repair Extend Healthspan?
Better genome maintenance may support healthier ageing—but promising does not mean proven.
Read this GVC →
A Risk Score Is a Snapshot. Health Is a Trajectory: 10P-Health in Action
Longitudinal modelling puts time back into personalised health—but prediction is not prevention.
Read this GVC →
Govern Health AI by the Decisions It Can Shape—not Only by the Benchmarks It Can Pass
Capability and authority are not the same: govern the decisions a deployed system can shape.
Read this GVC →
We’re Done Waiting: Interoperability Must Move from Policy to Execution
Interoperability’s bottleneck is no longer standards alone—it is coordinated execution.
Read this GVC →
Clinical AI Can Cause Harm—and Still Improve Physician Performance
The next safety frontier is how we design—and train—the human–AI team.
Read this GVC →
How Can We Make Health AI Safer?
Frequency matters: measure, escalate and compare preventable harm.
Read this GVC →
Who Broke the Healthcare System?
The healthcare system is shaped by institutions and leaders who set its rules—and must accept responsibility for reform.
Read this GVC →
Popular Peptide, Divided Regulatory Vote
Consumer demand may influence regulatory debate, but popularity cannot establish clinical efficacy or safety.
Read this GVC →
Humanoid Robots Have Entered the Operating Room
General-purpose humanoids have demonstrated preclinical surgical feasibility, but teleoperation is not autonomy.
Read this GVC →
194 Years? A Biological Model—Not a Longevity Promise
A theoretical ceiling can guide science—but it is not evidence that humans can reach it.
Read this GVC →
AI Is Becoming a Commercial Determinant of Health
AI is not only changing healthcare. It is changing how commercial power shapes health.
Read this GVC →
21% Fewer Deaths — and Still 1.16 Million Lost
Road-safety progress is real. The toll remains intolerable.
Read this GVC →
AI4H Sovereignty
Medical AI should be contextualised, validated and governed within the health system where it will be used.
Read this GVC →
Can Medical AI Forget?
Deleting patient data may not remove its influence from a trained medical AI model.
Read this GVC →
From Device to Care
Connected health is moving from monitoring toward clinical care and outcome-aligned payment.
Read this GVC →
No Automation Without Representation
Frontline clinicians need a real voice in how clinical AI is used.
Read this GVC →
One Trillion Minutes
One wearable foundation model transferred across 35 health-prediction tasks.
Read this GVC →
Younger—But Biologically Older
Later-born generations show greater biological ageing and a higher observed risk of early-onset cancer.
Read this GVC →
Evidence First
Traditional medicine must meet the same standards of efficacy and safety as every other intervention.
Read this GVC →
Protect the Craft
AI training on surgical expertise requires consent, transparency, ownership, and control.
Read this GVC →
Perverse Incentives
Health systems need incentives that reward prevention, outcomes, and long-term health.
Read this GVC →
Retraining
Physicians will increasingly need to act as scientific interpreters rather than protocol-followers.
Read this GVC →
A Blood Signature for Lung Cancer Risk
A 14-protein panel may identify elevated lung-cancer risk more than five years before diagnosis.
Read this GVC →
The $1.2 Quadrillion Opportunity
The economic value of extended healthspan could be enormous—but access will determine who benefits.
Read this GVC →
Who Drives Healthcare Costs?
A US survey finds that 81% of respondents identify corporate health insurers as the greatest influence.
Read this GVC →
RISE
Equitable AI for Health requires capacity, inclusive research, accessible infrastructure, and secure data practices.
Read this GVC →
AI Arms Race
When providers use AI to code and payers use AI to deny, the system may automate mistrust faster than care.
Read this GVC →
UK Biobank Data Leak
The exposure of participants’ medical details is a warning shot for health-data governance.
Read this GVC →
Financial Toxicity of Cancer
Cancer can carry severe financial consequences, including markedly higher bankruptcy risk and lower credit scores.
Read this GVC →
77 Cents for Biomedical Data
The gap between AI investment and sustained biomedical-data investment remains extraordinary.
Read this GVC →